Beneficial effects of mechanical reperfusion therapy on left ventricular remodeling and late outcome following myocardial infarction

Japanese Heart Journal

Volumn 39, Issue 4, 1998, Pages 419-433

  Sakakibara, Masayoshi ^a   Tochiki, Hidetaka ^a   Sasaki, Toshio ^a   Kunishima, Tomoyuki ^a   Nagashima, Junzou ^a   Miyake, Fumihiko ^a   Murayama, Masahiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMI; ICT; Late outcome; Left ventricular remodeling; PTCA; Reperfusion therapy; RWMI

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE VOLUME; HEART VENTRICULOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0031817127     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.39.419     Document Type: Article

References (41)

1. Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: 354-63.
2. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction: a review. Drugs 1992; 44: 293-325.
3. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
4. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival, after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
5. ISIS-2 (second international study of infarct survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-60.
6. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
7. Grines CL, Browne KF, Macro J, et al. for The Primary Angioplasty in Myocardial Infarction Study group. A Comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
8. Gibbons RJ, Holmes DR, Reeder GS, Bayley KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-91.
9. de Boer MJ, Suryapranata H, Hoorntje JCA, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in myocardial infarction. Circulation 1994, 90: 753-61.
10. de Boer MJ, Reiber JHC, Suryapranata H, Van den Brand MJBM, Hoorntje JCA, Zijlstra F. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J 1995; 16: 1347-55.
11. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 1992; 20: 307-13.
12. Ohman EM, Califf RM, Topol EJ, et al. and TAMI Study Group. Consequence of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781-91.
13. O'Neill W, Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986; 314: 812-8.
14. Rentrop PK, Thronton JC, Feit F, Buskirk M. Determinants and protective potential of coronary collaterals as assessed by angioplasty model. Am J Cardiol 1988; 61: 677-84.
15. Sandier H, Dodge HT. The use of single plane angiocardiography for the measurement of left ventricular volume in man. Am Heart J 1968; 75: 325-34.
16. Dodge HT, Sandier H, Baxley WA, Hawley RR. Usefulness and limitation of radiographic methods for determining left ventricular volume. Am J Cardiol 1966; 18: 10-24.
17. Sheehan FH, Mathey DG, Schofer J, Krebber H-J, Dodge HT. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. AmJ Cardiol 1983; 52: 431-8
18. Austen WG, Edwards JE, Frye RL, et al A reporting system on patients evaluated for coronary artery disease Circulation 1975; 51 AHA Page 5-40.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-81.
20. Simons ML, Serruys PW, Brand M, et al. Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival. J Am Coll Cardiol 1986; 7: 717-28.
21. Serruys PW, Simons ML, Suryapranata H, et al. for the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Cardiology Institute. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986; 7: 729-42.
22. Ellis SG, O'Neill WW, Bates ER, Walton JA, Nabel EG, Topol EJ. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset; report of an initial experience. J Am Coll Cardiol 1989; 13: 1122-6.
23. Roig E, Castaner A, Simmons B, Patel R, Ford E, Cooper R. In-hospital mortality rates from acute myocardial infarction by race in US hospitals: findings from the National Hospital Discharge Survey. Circulation 1987; 76: 280-8.
24. Norris RM, Brandt PWT, Caughey DE, Lee AJ, Scott PJ. A new coronary prognostic index. Lancet 1969; I: 274-8.
25. Hillis LD, Forman S, Braunwald E, and Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. Risk stratification before thrombolytic therapy in patients which acute myocardial infarction. J Am Coll Cardiol 1990; 16: 313-5.
26. Maggioni AP, Franzosi JG, Santoro E, White H, Van de Werf F, Tognoni G, on behalf of the GISSI-2 and International Study Groups. Analysis of the risk of stroke in 20,891 patients with acute myocardial infarction following thrombolytic and antithrombotic treatment. N Engl J Med 1992; 327: 1-6.
27. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J 1993; 307: 349-53.
28. Lee KL, Woodlief LH, Topol EJ, et al. for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995; 91: 1659-68.
29. Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1978; 61: 1048-56.
30. Blanke H, von Hardenberg D, Cohen M, et al. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size. J Am Coll Cardiol 1984; 3: 675-80.
31. Hirayama A, Adachi T, Asada S, et al. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation. 1993; 88: 2565-74.
32. Schaer DH, Ross AM, Wasserman AG. Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. Circulation 1987; 76: Suppl II: II-57-62.
33. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT study. Circulation 1993; 87: 1524-30.
34. White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987; 317: 850-5.
35. Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: The GISSI (Gruppo Italiano per lo Studio della streptochinase nell' Infarto Miocardico) trial. J Am Coll Cardiol 1989; 14: 1149-58.
36. Gadsboll N, Hoilund-Carlsen P, Badsberg JH, Stage P, Marving J, Lonborg-Jensen BH. Left ventricular dilatation in survivors of acute myocardial infarction. Am J Cardiol 1989; 64: 961-6.
37. Ward SR, Sutton JM, Pieper KS, Schwaiger M, Califf RM, Topol EJ, for the TAMI investigators. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. Am J Cardiol 1997; 79: 539-44.
38. Zijlstra F, de Boer MJ, Beukema WP, et al. Mortality, reinfarction, left ventricular ejection fraction and cost following reperfusion therapies for acute myocardial infarction. Eur Heart J 1996; 17: 382-7.
39. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-8.
40. Terrin ML, Williams DO, Kleiman NS, et al. for the TIMI II investigators. Two- and three-year results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial. J Am Coll Cardial 1993; 22: 1763-72.
41. Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL, for the Alabama Registry of myocardial ischemia investigators. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1994; 74: 111-8.